v2act immunotherapy
v2act immunotherapy: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| GENELUX Corp (GNLX) | Phase 1/Phase 2 |
Get deeper analysis on v2act immunotherapy
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis